MacroGenics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.

About MGNX

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.

CEO

Scott E. Koenig

CEOScott E. Koenig

Employees

339

Employees339

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2000

Founded2000

Employees

339

Employees339

MGNX Key Statistics

Market cap

977.82M

Market cap977.82M

Price-Earnings ratio

-102.63

Price-Earnings ratio-102.63

Dividend yield

—

Dividend yield—

Average volume

1.10M

Average volume1.10M

High today

$16.33

High today$16.33

Low today

$15.24

Low today$15.24

Open price

$15.96

Open price$15.96

Volume

1.03M

Volume1.03M

52 Week high

$21.88

52 Week high$21.88

52 Week low

$4.29

52 Week low$4.29

Analyst ratings

91%

of 11 ratings

Buy

90.9%

Hold

9.1%

Sell